Boston-based Beta Bionics, whose automated insulin dosing software the FDA approved in May 2023, raised a $100M Series D, taking its total funding to $293.5M (Andrea Park/Fierce Biotech) 01-09-2023
Andrea Park / Fierce Biotech: Boston-based Beta Bionics, whose automated insulin dosing software the FDA approved in May 2023, raised a $100M Series D, taking its total funding to $293.5M — In the wake of earning FDA clearance for its insulin pump an | In the wake of earning FDA clearance for its insulin pump … Lees verder op Tech Meme